Infection with hepatitis B virus (HBV) leads to a wide spectrum of clinical presentations
ranging from an asymptomatic carrier state to self-limited acute or fulminant hepatitis to …

A wide variety of commercial assays is available for the detection of hepatitis B surface
antigen (HBsAg). Clearly, the sensitivity of an assay to detect a variant is dependent on the …

In chronic hepatitis B (CHB), the persistence of hepatitis B surface antigen (HBs Ag) is
sometimes associated with antibodies (Ab) to HBs (anti-HBs). To assess the hypothesis of …

Background & Aims HBV immune escape represents a challenge to prevention, diagnosis,
and treatment of hepatitis B. Here, we analyzed the molecular and clinical characteristics of …

BACKGROUND & AIMS: Despite the success of a universal vaccination program against
hepatitis B virus (HBV) in Taiwan, a small but substantial proportion of individuals remain …

Hepatitis B (HBV) virus infects the liver, and upon chronic infection, can cause liver cirrhosis
and hepatocellular carcinoma. Despite universal vaccination programs against the virus …

During hepatitis B virus (HBV) infection, at least four antigen–antibody systems are
observed: HBsAg and anti-HBs; preS antigen and anti-preS antibody; HBcAg and anti-HBc; …

Human hepatitis B virus (HBV) infects the liver of humans or humanoid primates. In humans,
HBV infection often causes an inflammatory liver disease–hepatitis B. The virus is …

To control hepatitis B virus (HBV) infection, a universal HBV vaccination program for infants
was launched in Taiwan in 1984. The aim of this study was to investigate the role of B‐cell …

The coexistence of HB sAg and anti‐HB s is an atypical serological pattern in HBV infection.
There is no epidemiological characteristics of this serological pattern in the community and …